We have collected information about Eyegate Ii Delivery System for you. Follow the links to find out details on Eyegate Ii Delivery System.
http://www.eyegatepharma.com/
The EyeGate Platforms Our proprietary technology, the EyeGate® II Delivery System, utilizes transscleral iontophoresis to deliver optimal therapeutic levels of drug directly into the targeted ocular tissue.
http://www.eyegatepharma.com/technology/iontophoresis-delivery-system/
Our proprietary technology, the EyeGate® II Delivery System, utilizes transscleral iontophoresis to deliver optimal therapeutic levels of drug directly into the targeted ocular tissue. It offers a potential alternative to current delivery modalities such as eye drops and ocular injections.
https://www.medgadget.com/2018/04/eyegate-non-invasive-system-uses-electricity-to-pull-drug-into-eye.html
The EyeGate II iontophoresis drug delivery system instead relies on electric current to pull an ionizable drug into the eye. This is achieved by placing an electrode on the forehead of the patient, while having the opposite electrode within the applicator carrying the drug.
https://www.youtube.com/watch?v=v7oSLe-bLWo
Dec 23, 2013 · This is a video demonstration of the EyeGate II Delivery System. Morgan Freeman Chats with Jimmy While Sucking Helium - Duration: 3:15. The Tonight Show Starring Jimmy Fallon Recommended for youAuthor: MadDash
https://eyetube.net/video/genop/
Oct 21, 2010 · EyeGate II Delivery System Channels: Posted 10/21/2010 The following video shows a patient being treated with the EyeGate II, an iontophoretic platform that delivers therapeutics into the …
https://www.equitynet.com/c/eyegate-pharmaceuticals
EyeGate Pharma is developing a proprietary platform of medicines to treat diseases of the eye using its unique, non-invasive, iontophoretic drug-delivery system called EyeGate II. This proprietary technology platform is based on over 10-years of development at the Bascom Palmer Eye Institute at the University of Miami and has been tested extensively in both preclinical and human studies in Europe.
https://insiderfinancial.com/eyegate-pharmaceuticals-inc-nasdaqeyeg-likely-takeover-candidate/114357/
Eyegate CEO Stephen From said: “The interim results of the trial are highly promising and suggest the ability of the EyeGate(R) II Delivery System to deliver drug to the posterior segment of the eye, which could present important new opportunities for our iontophoretic technology and drug formulations in additional disease indications.
Searching for Eyegate Ii Delivery System?
You can just click the links above. The data is collected for you.
